The effect of etanercept on hepatic fibrosis risk in patients with non-alcoholic fatty liver disease, metabolic syndrome, and psoriasis

Obesity and Fatty Liver Are ‘Grease’ for the Machinery of Hepatic Fibrosis

(2017) Anja Bosserhoff et al.   DIGESTIVE DISEASES

Association between obesity measured by different parameters and severity of psoriasis

(2012) Gleison Vieira Duarte et al.   INTERNATIONAL JOURNAL OF DERMATOLOGY

From the metabolic syndrome to NAFLD or vice versa?

(2010) Ester Vanni et al.   DIGESTIVE AND LIVER DISEASE

Practice guidelines for the diagnosis and management of nonalcoholic fatty liver disease

(2010) P. Loria et al.   DIGESTIVE AND LIVER DISEASE

The role of fructose in the pathogenesis of NAFLD and the metabolic syndrome

(2010) Jung Sub Lim et al.   Nature Reviews Gastroenterology & Hepatology

Nonalcoholic fatty liver disease: A manifestation of the metabolic syndrome

(2009) C. H. KIM et al.   CLEVELAND CLINIC JOURNAL OF MEDICINE

Effects of tumor necrosis factor-α blockade on metabolic syndrome components in psoriasis and psoriatic arthritis and additional lessons learned from rheumatoid arthritis

(2009) Jennifer Channual et al.   Dermatologic Therapy

Non-alcoholic fatty liver disease in patients with chronic plaque psoriasis

(2009) Paolo Gisondi et al.   JOURNAL OF HEPATOLOGY

Prevalence, characteristics and severity of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis

(2009) Luca Miele et al.   JOURNAL OF HEPATOLOGY

Pathogenesis of non-alcoholic fatty liver disease

(2009) J. K. Dowman et al.   QJM-AN INTERNATIONAL JOURNAL OF MEDICINE